Since our inception 15 years ago, Equashield's sole mission is to protect healthcare workers from the risks associated with exposure to hazardous drugs. We are the most used CSTD in the USA for the past 6 years running due to our unique 100% fully closed barrier CSTD and we supply pharmacists and nurses in 30 countries around the World. We launched operations in the UK in 2023. Our unique range of fully closed drug transfer devices works in tandem with Mundus Mini HD and includes our unique fully-closed back syringe range to stop release of harmful drug vapours from the back of the syringe as with standard syringes; a range of solutions that offers the safest, most effective method of pharmacy production, transport and administration. Equashield are leading the way in 2024 with a new range of automated compounding robots - the first of which, the Mundus HD Mini robot launched in 2023 in USA and in the EU in March 2024 and at Clinical Pharmacy Congress in London in May 2024. Mundus provides state-of-the-art AI-driven, safe and efficient drug compounding with closed system transfer devices to improve workflow, assist pharmacies with increasing patients' requirements and so that all healthcare personnel who work with, or around hazardous drugs are protected for the whole lifecycle of the drug - from production through to incineration of hazardous drug waste.